Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RALPH BOCCIA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1881663284
CMS profile
175674
Location
BETHESDA, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$433,660.62

450 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Ownership and Investment Interests

CMS also publishes Ownership and Investment Interests as a separate dataset. This site does not currently mirror it, and no ownership figure is shown on this page. This provider appears in that dataset.

Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Fennec Pharmaceuticals, Inc. $102,510.93 20
Pharmacosmos Therapeutics Inc. $48,193.83 37
Janssen Biotech, Inc. $37,818.71 45
SOBI, INC $37,747.26 31
BeiGene USA, Inc. $31,765.20 21
Regeneron Healthcare Solutions, Inc. $29,282.03 28
ABBVIE INC. $28,330.00 26
Karyopharm Therapeutics Inc. $19,451.00 12
Genmab U.S., Inc. $18,270.79 14
Daiichi Sankyo Inc. $13,495.96 26
Stemline Therapeutics Inc. $12,085.98 8
GENZYME CORPORATION $11,483.84 12
Rigel Pharmaceuticals, Inc. $8,743.95 14
Celgene Corporation $7,306.80 19
Amgen Inc. $5,421.72 3
Novocure Inc. $4,875.00 3
Lilly USA, LLC $4,613.46 5
Novartis Pharmaceuticals Corporation $3,563.80 16
AstraZeneca Pharmaceuticals LP $2,659.44 18
Ipsen Biopharmaceuticals, Inc $2,198.64 2
TAIHO ONCOLOGY, INC. $1,342.93 2
PFIZER INC. $362.05 13
Astellas Pharma US Inc $154.06 6
Merck Sharp & Dohme LLC $150.36 6
Eli Lilly and Company $132.26 1
Sumitomo Pharma America, Inc. $132.13 3
ACCORD HEALTHCARE, INC. $124.19 1
GlaxoSmithKline, LLC. $110.83 4
Incyte Corporation $104.94 3
Takeda Pharmaceuticals U.S.A., Inc. $100.58 4
E.R. Squibb & Sons, L.L.C. $94.33 4
Adaptive Biotechnologies Corporation $85.06 1
Eisai Inc. $75.13 3
Exelixis Inc. $72.80 3
Mirati Therapeutics, Inc. $70.76 2
ARRAY BIOPHARMA INC $64.77 3
PharmaEssentia USA Corporation $64.29 2
Tempus AI, Inc $56.93 2
PUMA BIOTECHNOLOGY, INC. $53.37 3
Blueprint Medicines Corporation $49.42 2
Kite Pharma, Inc. $49.07 2
Gilead Sciences, Inc. $49.02 2
SERVIER PHARMACEUTICALS LLC $35.62 1
Acrotech Biopharma Inc. $31.43 2
Myriad Genetic Laboratories, Inc. $31.16 2
Dendreon Pharmaceuticals LLC $25.38 1
Kyowa Kirin, Inc. $20.72 1
TerSera Therapeutics LLC $20.24 1
Janssen Pharmaceuticals, Inc $19.80 1
Apellis Pharmaceuticals, Inc. $19.65 1
Immunocore Limited $19.02 1
SpringWorks Therapeutics, Inc. $19.01 1
Alnylam Pharmaceuticals Inc. $18.90 1
Bayer Healthcare Pharmaceuticals Inc. $18.80 1
Secura Bio, Inc. $17.73 1
Deciphera Pharmaceuticals Inc. $17.33 1
CashFlow Solutions, LLC $14.47 1
RECORDATI_RARE_DISEASES_INC. $13.74 1

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

450 matching records · $433,660.62 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 450 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 450.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Fennec Pharmaceuticals, Inc. $139.3709/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120186914 CMS
Fennec Pharmaceuticals, Inc. $20,000.0009/30/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120186936 CMS
Fennec Pharmaceuticals, Inc. $7,000.0009/27/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120186934 CMS
Astellas Pharma US Inc $31.5209/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139417797 CMS
Fennec Pharmaceuticals, Inc. $22,000.0009/26/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120186932 CMS
Janssen Biotech, Inc. $29.9809/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078713640 CMS
SOBI, INC $67.3509/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141423445 CMS
Tempus AI, Inc $29.1909/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261150161409 CMS
AstraZeneca Pharmaceuticals LP $32.7909/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104584230 CMS
Stemline Therapeutics Inc. $3,900.0009/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142963212 CMS
Stemline Therapeutics Inc. $774.0009/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142963214 CMS
Celgene Corporation $214.8109/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101121876 CMS
Celgene Corporation $214.8109/19/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101121874 CMS
Celgene Corporation $16.8309/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101121868 CMS
Celgene Corporation $44.8809/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101121870 CMS
Celgene Corporation $16.8309/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101121872 CMS
Celgene Corporation $214.8109/18/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101121878 CMS
Celgene Corporation $5,943.3709/18/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101121880 CMS
Celgene Corporation $16.8309/18/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261155175013 CMS
Celgene Corporation $16.8309/18/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261155175015 CMS
Celgene Corporation $44.8809/18/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261155175017 CMS
PFIZER INC. $33.2209/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131455807 CMS
Celgene Corporation $214.8109/17/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101121882 CMS
Janssen Biotech, Inc. $28.8209/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078713911 CMS
Lilly USA, LLC $44.4309/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261135331049 CMS
Janssen Biotech, Inc. $23.5909/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078714303 CMS
Rigel Pharmaceuticals, Inc. $24.1109/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261145209157 CMS
Acrotech Biopharma Inc. $14.7509/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261147104706 CMS
Novartis Pharmaceuticals Corporation $26.9409/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086714057 CMS
ARRAY BIOPHARMA INC $24.9209/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261132016331 CMS
ABBVIE INC. $26.5509/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103340934 CMS
Novartis Pharmaceuticals Corporation $31.3109/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086714055 CMS
PUMA BIOTECHNOLOGY, INC. $19.1309/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261113857183 CMS
Stemline Therapeutics Inc. $2,340.0009/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142963218 CMS
Celgene Corporation $34.7209/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101121862 CMS
GENZYME CORPORATION $35.1808/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139648574 CMS
Mirati Therapeutics, Inc. $35.0408/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261117166720 CMS
BeiGene USA, Inc. $2,250.0008/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120858295 CMS
Lilly USA, LLC $20.8008/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261135331053 CMS
Janssen Pharmaceuticals, Inc $19.8008/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078043870 CMS
AstraZeneca Pharmaceuticals LP $48.3108/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104535235 CMS
SOBI, INC $25.1908/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141426879 CMS
Janssen Biotech, Inc. $1,500.0008/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078714108 CMS
Novartis Pharmaceuticals Corporation $22.0408/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086714079 CMS
AstraZeneca Pharmaceuticals LP $21.3608/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104708923 CMS
BeiGene USA, Inc. $2,250.0008/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120858297 CMS
Stemline Therapeutics Inc. $101.3108/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142963216 CMS
Janssen Biotech, Inc. $1,500.0008/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078714542 CMS
PFIZER INC. $28.2108/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131898781 CMS
AstraZeneca Pharmaceuticals LP $22.7308/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105602920 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $707,458.24 649
PY2020 $452,016.98 405
PY2021 $393,668.10 454
PY2022 $493,041.79 506
PY2023 $415,808.04 493
PY2024 $433,660.62 450
PY2025 $244,074.29 326

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
RALPH BOCCIA, NPI 1881663284. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1881663284.
APA 7
IndustryPayments. (2026). RALPH BOCCIA, NPI 1881663284 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1881663284
Bluebook
RALPH BOCCIA, NPI 1881663284, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1881663284.

Source: Centers for Medicare & Medicaid Services, Open Payments.